COMP <GO>
KYMR vs HALO // EV/EBITDA & P/E VALUATION
Kymera Therapeutics Inc. (NASDAQ) VS. Halozyme Therapeutics Inc. (NASDAQ) • 15-METRIC TALLY: KYMR 4
— HALO 7
■ METRIC PARITY
LAST: $127.51 (+0.70%) • MKT CAP: $10.81B
valuation
—
LAST: $128.95 (-1.50%) • MKT CAP: $14.86B
valuation
35.6x
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (KYMR VS. HALO)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | KYMR | HALO | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | — | 83.60% | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -21.40% | 18.00% | -39.40 | HALO | /roic <GO> |
| EV/EBITDA & P/E Valuation ACTIVE | — | 35.6x | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | -2.30% | 4.33% | -6.63 | HALO | /fcf-yield <GO> |
| Operating Margin | -60.00% | 33.60% | -93.60 | HALO | /operating-margins <GO> |
| Net Profit Margin | 68.00% | 22.70% | +45.30 | KYMR | /net-margins <GO> |
| Revenue Growth (YoY) | -16.70% | 37.60% | -54.30 | HALO | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 26.00 | 5.11 | +20.89 | KYMR | /balance-sheet <GO> |
| Piotroski F-Score Quality | 4/9 | 7/9 | -3.00 | HALO | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 66.0 | 77.8 | -11.80 | HALO | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 0.95 | 0.88 | +0.07 | KYMR | /macro-sensitivity <GO> |
| Forward P/E Multiple | 30.4x | 39.5x | -9.10 | KYMR | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $10.81B | $14.86B | -$4.05B | HALO | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | KYMR REV | HALO REV | KYMR GROSS % | HALO GROSS % | KYMR FCF | HALO FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $39.2M | $1.40B | 0.0% | 83.6% | -$234.3M | $644.6M |
| FY 2024 | $47.1M | $1.02B | 0.0% | 84.3% | -$207.3M | $468.4M |
| FY 2023 | $78.6M | $829.3M | — | — | -$106.4M | $351.3M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
KYMR // BETA 0.95
HALO // BETA 0.88